Quest Integrity v. Cokebusters Puts Cloud-Based Medical Diagnostic Patents at Risk of On-Sale Bar
February 7, 2020
By: Matthew Murphy
Medical Device and Diagnostic Industry
Axinn counsel Matthew Murphy authored the Medical Device and Diagnostic Industry article, "Quest Integrity v. Cokebusters Puts Cloud-Based Medical Diagnostic Patents at Risk of On-Sale Bar."
Click here to access the article.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
GCR Live: Law Leaders Europe 2025
Speaking Engagement
Antitrust
Navigating Compliance: How the 2025 Hart-Scott-Rodino Updates Are Impacting Businesses
Webinar
Antitrust
AHLA Annual Meeting 2025
Speaking Engagement
Antitrust
SABA North America Annual Conference 2025
Speaking Engagement
Antitrust
Patman Returns … and Retreats Again
Axinn Viewpoints
Antitrust
Axinn Successfully Reunites One of Its Pro Bono Clients, a Former Afghan Army Captain, with His Wife and Four Children
Pro Bono
The Texas v. Blackrock ESG Case: The FTC and DOJ Have Entered the Chat
Axinn Viewpoints
Volunteer Lawyers for the Arts – Champions of the Arts Awards and Gala 2025
Sponsorship
Antitrust
Washington Lawyers’ Committee for Civil Rights and Urban Affairs – 2025 Wiley A. Branton Awards Luncheon
Sponsorship
Antitrust
What's Happening in Germany and Portugal? Catching Up With International Enforcers at the 2025 Spring Meeting
Podcast
Antitrust